Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

intervet international bv - indoxacarb, permethrin - permetríni, sturtu, ectoparasiticides fyrir baugi nota, meðtalin. skordýraeitur - hundar - meðferð á flóaæxli (ctenocephalides felis); varan hefur viðvarandi skordýraeitrun í allt að 4 vikur gegn ctenocephalides felis. vara hefur viðvarandi acaricidal virkni fyrir upp að 5 vikur gegn ixodes ricinus og upp að 3 vikur gegn rhipicephalus sanguineus. eitt meðhöndlun veitir repellent (gegn fóðrun) virkni gegn sandiflugum (phlebotomus perniciosus) í allt að 3 vikur.

Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

pfizer limited  - metaflumizone, amitraz - ectoparasiticides fyrir baugi nota, meðtalin. skordýraeitur - hundar - til meðhöndlunar og forvarnar gegn áföllum með flórum (ctenocephalides canis og c. sus), og ticks (ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus, dermacentor reticulatus og dermacentor variabilis), og meðferð demodicosis (af völdum demodex spp. ) og lús (trichodectes canis) hjá hundum. dýralyfið er hægt að nota sem hluti af meðferðaráætlun fyrir húðsjúkdóm í húðflóa (fad).

Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - eitilfrumukrabbamein, mantle-cell - Æxlishemjandi lyf - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Eiropas Savienība - īslandiešu - EMA (European Medicines Agency)

3m health care limited - rivastigmin - alzheimer sjúkdómur - psychoanaleptics, , anticholinesterases - einkennum meðferð vægt til nokkuð alvarlega alzheimer heilabilun.

Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - mixtúra, dreifa - 1 mg/ml

Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 5 mg

Īslande - īslandiešu - LYFJASTOFNUN (Icelandic Medicines Agency)

astellas pharma a/s* - solifenacinum súkkínat - filmuhúðuð tafla - 10 mg